Streetbeat News

Analyst Ratings

CAPR

Oppenheimer analyst Leland Gershell has reiterated an 'Outperform' rating for Capricor Therapeutics, maintaining a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:29 pm

KR

Melius Research has initiated coverage on Kroger with a Hold rating and set a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:28 pm

MNSO

B of A Securities has downgraded MINISO Group Holding (NYSE:MNSO) from Buy to Underperform, indicating a negative outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:27 pm

DG

Melius Research has initiated coverage on Dollar General (NYSE:DG) with a Hold rating and set a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:25 pm

GO

Melius Research has initiated coverage on Grocery Outlet Holding with a Hold rating and set a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:23 pm

VTYX

HC Wainwright & Co. analyst Emily Bodnar has reiterated a Neutral rating for Ventyx Biosciences (NASDAQ:VTYX) and maintained a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:23 pm

CNTX

HC Wainwright & Co. analyst Emily Bodnar has reiterated a Buy rating for Context Therapeutics (NASDAQ:CNTX) and maintained a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:21 pm

BHVN

Baird analyst Brian Skorney maintains an Outperform rating on Biohaven (NYSE:BHVN) and raises the price target from $58 to $60.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:20 pm

CIEN

GM

INTC

QCOM

TSLA

VKTX

US stocks opened the week flat as investors await clarity on economic and political fronts. Gold hit record highs, while Tesla surged 4% amid a proposed export ban on Chinese vehicles. Intel rose on Qualcomm takeover rumors, and Ciena received a double upgrade from Citigroup.

Portfolio Pulse from Piero Cingari

September 23, 2024 | 5:20 pm

BLCO

HC Wainwright & Co. analyst Yi Chen maintains a Buy rating on Bausch & Lomb (NYSE:BLCO) and raises the price target from $19 to $22.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:17 pm